Last week, Florida’s surgeon general released a memo on the “treatment of gender dysphoria for children and adolescents.” The document seeks to “clarify” assertions made in a Department of Health and Human Services “fact-sheet” about trans-identifying youth. Whereas the HHS document claimed that “early affirming care is crucial to overall health and well-being,” Florida’s one-page summary warns of “low-quality evidence, small sample sizes, and medium to high risk of bias.”
Insofar as the guidelines caution against gender-transitioning drugs and surgeries for minors, Florida is following Europe’s lead. The Florida memo does go further in its explicit caution against social transitions, however.
Comments